Further, new clinical studies investigating the cognitive profiles of ADHD, ASD, and SCA3, are necessary to gain insight into the nuances of the disorders which in turn can improve the differential diagnosis and the potential to identify sub-cognitive phenotypes of patients with ADHD and ASD, which in turn may help us develop better treatments and strategies. This evidence concerns the gene ATXN3 and attention deficit-hyperactivity disorder.